Somatic Genetic Testing Global Market Report 2025

Description

Somatic genetic testing refers to the comprehensive analysis of genetic mutations that occur in non-reproductive (somatic) cells over a person's lifetime, most often within tumor tissues. It plays a vital role in cancer diagnosis and treatment by detecting specific genetic alterations that can be targeted with personalized therapies, while also helping to predict disease progression and support clinical decision-making.

The key types of somatic genetic testing include targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels involve analyzing a defined group of genes linked to a particular disease or condition, allowing for accurate and cost-effective diagnosis. This testing can be performed using a range of sample types, such as tissue-based samples, blood samples, bone marrow aspirates, and others. It employs advanced technologies including polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. Somatic genetic testing is applied in various areas such as cancer diagnosis, cardiovascular diseases, neurological disorders, inherited genetic conditions, and others, and is utilized by end users including hospitals, clinical laboratories, research institutes, at-home testing providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The somatic genetic testing market size has grown rapidly in recent years. It will grow from $6.81 billion in 2024 to $7.78 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth during the historic period can be attributed to increasing awareness of genetic disorders, the rising prevalence of cancer, greater adoption of genetic testing in clinical settings, the expansion of healthcare infrastructure, and growing patient demand for personalized treatment.

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to the increasing focus on early disease detection, rising collaborations between biotechnology and pharmaceutical companies, the expansion of public-private partnerships, and greater availability of advanced diagnostic tools. Key trends expected during this period include technological progress in sequencing, innovations in bioinformatics and artificial intelligence, increased investment in research and development, the advancement of non-invasive testing methods, and continued innovations in next-generation sequencing platforms.

The rising incidence of cancer is expected to drive the growth of the somatic genetic testing market in the coming years. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increasing burden of cancer is linked to lifestyle factors such as unhealthy diets, smoking, physical inactivity, and excessive alcohol consumption. Somatic genetic testing supports cancer diagnosis by identifying tumor-specific genetic mutations, enabling targeted and personalized treatment strategies. It also reduces the need for invasive procedures through advanced technologies, enhancing diagnostic accuracy and improving patient outcomes. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency, reported that the number of cancer cases diagnosed in Australia reached 160,570 in 2022, an increase of 3,789 cases from 156,781 in 2021. Consequently, the growing incidence of cancer is fueling demand for somatic genetic testing.

Companies in the somatic genetic testing market are focusing on advanced diagnostic solutions such as liquid biopsy tests to improve precision, enable early detection, and reduce reliance on invasive procedures. Liquid biopsy refers to a non-invasive method of analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples to identify cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation sequencing (NGS)-based solution designed to detect ctDNA from blood samples. This test identifies somatic mutations across 74 key cancer-related genes, supporting personalized cancer care by pinpointing actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without traditional tissue biopsies. It facilitates precision oncology by guiding targeted therapies and tracking disease progression or resistance in real time.

In December 2022, Prenetics Global Limited, a China-based genetic testing company, acquired ACT Genomics Holdings Company Limited for an undisclosed sum. Through this acquisition, Prenetics gains access to ACT Genomics' cancer testing technologies, including NGS, bioinformatics, and genome profiling, to enhance both somatic and germline testing across Asia and beyond. ACT Genomics Holdings Company Limited, based in Taiwan, specializes in somatic genetic testing for cancer patients.

Major players in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Somatic Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Carrier Screening; Other Testing Methods
2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Inherited Genetic Disorders; Other Applications
5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; At-Home Testing Providers; Other End-Users
Subsegments:
1) By Targeted Gene Panels: Oncology Panels; Neurology Panels; Cardiovascular Panels; Rare Disease Panels; Pharmacogenomics Panels
2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
4) By Carrier Screening: Expanded Carrier Screening; Ethnicity-Based Carrier Screening; Universal Carrier Screening
5) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37892

1. Executive Summary

2. Somatic Genetic Testing Market Characteristics

3. Somatic Genetic Testing Market Trends And Strategies

4. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Somatic Genetic Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Somatic Genetic Testing Market Growth Rate Analysis
5.4. Global Somatic Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Somatic Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Somatic Genetic Testing Total Addressable Market (TAM)

6. Somatic Genetic Testing Market Segmentation

6.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Gene Panels
Whole Exome Sequencing
Whole Genome Sequencing
Carrier Screening
Other Testing Methods
6.2. Global Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tissue-Based
Blood-Based
Bone Marrow Aspirates
Other Samples
6.3. Global Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Microarray
Sanger Sequencing
Other Technologies
6.4. Global Somatic Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Diagnosis
Cardiovascular Disorders
Neurological Disorders
Inherited Genetic Disorders
Other Applications
6.5. Global Somatic Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinical Laboratories
Research Institutes
At-Home Testing Providers
Other End-Users
6.6. Global Somatic Genetic Testing Market, Sub-Segmentation Of Targeted Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology Panels
Neurology Panels
Cardiovascular Panels
Rare Disease Panels
Pharmacogenomics Panels
6.7. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Whole Exome Sequencing
Clinical Research Whole Exome Sequencing
Population-Based Whole Exome Sequencing
6.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Whole Genome Sequencing
Research Whole Genome Sequencing
De Novo Whole Genome Sequencing
Cancer Whole Genome Sequencing
6.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Expanded Carrier Screening
Ethnicity-Based Carrier Screening
Universal Carrier Screening
6.10. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Copy Number Variation Testing
Mitochondrial Deoxyribonucleic Acid (DNA) Testing
Ribonucleic Acid (RNA) Sequencing
Epigenetic Testing

7. Somatic Genetic Testing Market Regional And Country Analysis

7.1. Global Somatic Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Somatic Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Somatic Genetic Testing Market

8.1. Asia-Pacific Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Somatic Genetic Testing Market

9.1. China Somatic Genetic Testing Market Overview
9.2. China Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Somatic Genetic Testing Market

10.1. India Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Somatic Genetic Testing Market

11.1. Japan Somatic Genetic Testing Market Overview
11.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Somatic Genetic Testing Market

12.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Somatic Genetic Testing Market

13.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Somatic Genetic Testing Market

14.1. South Korea Somatic Genetic Testing Market Overview
14.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Somatic Genetic Testing Market

15.1. Western Europe Somatic Genetic Testing Market Overview
15.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Somatic Genetic Testing Market

16.1. UK Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Somatic Genetic Testing Market

17.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Somatic Genetic Testing Market

18.1. France Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Somatic Genetic Testing Market

19.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Somatic Genetic Testing Market

20.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Somatic Genetic Testing Market

21.1. Eastern Europe Somatic Genetic Testing Market Overview
21.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Somatic Genetic Testing Market

22.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Somatic Genetic Testing Market

23.1. North America Somatic Genetic Testing Market Overview
23.2. North America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Somatic Genetic Testing Market

24.1. USA Somatic Genetic Testing Market Overview
24.2. USA Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Somatic Genetic Testing Market

25.1. Canada Somatic Genetic Testing Market Overview
25.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Somatic Genetic Testing Market

26.1. South America Somatic Genetic Testing Market Overview
26.2. South America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Somatic Genetic Testing Market

27.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Somatic Genetic Testing Market

28.1. Middle East Somatic Genetic Testing Market Overview
28.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Somatic Genetic Testing Market

29.1. Africa Somatic Genetic Testing Market Overview
29.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Somatic Genetic Testing Market Competitive Landscape And Company Profiles

30.1. Somatic Genetic Testing Market Competitive Landscape
30.2. Somatic Genetic Testing Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Somatic Genetic Testing Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. QIAGEN N.V.
31.3. Exact Sciences Corp.
31.4. ARUP Laboratories Inc.
31.5. Natera Inc.
31.6. Myriad Genetics Inc.
31.7. Fulgent Genetics Inc.
31.8. Invitae Corporation
31.9. NeoGenomics Laboratories Inc.
31.10. Guardant Health Inc.
31.11. MedGenome Labs Ltd.
31.12. Caris Life Sciences Inc.
31.13. Oxford Nanopore Technologies Ltd.
31.14. Pacific Biosciences of California Inc.
31.15. Invivoscribe Inc.

32. Global Somatic Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Somatic Genetic Testing Market

34. Recent Developments In The Somatic Genetic Testing Market

35. Somatic Genetic Testing Market High Potential Countries, Segments and Strategies

35.1 Somatic Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Somatic Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Somatic Genetic Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer